Reddoch James F. insider trades
Reddoch James F. has filed 9 Form 4s with the SEC that we hold, all for Royalty Pharma plc (RPRX), as EVP & Chief Scientific Officer. Across all of them we count 0 purchases worth $0 and 12 sales worth $18.9M reported on Form 4. None of these purchases or sales is dated in the last 12 months. The largest single trade was a sale of 100,000 shares of Royalty Pharma plc worth $4.2M, dated 2022-06-08. The first filing on our record is dated 2021-07-08 and the latest 2022-09-30.
Royalty Pharma plc (RPRX)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2021-07-06 | S, sale reported on Form 4 | 30,270 | $1.3M | 2021-07-08 |
| 2021-07-07 | S, sale reported on Form 4 | 2,192 | $92.1K | 2021-07-08 |
| 2021-07-08 | S, sale reported on Form 4 | 40,655 | $1.7M | 2021-07-08 |
| 2021-07-12 | S, sale reported on Form 4 | 100 | $4.2K | 2021-07-14 |
| 2021-07-13 | S, sale reported on Form 4 | 17,832 | $749.1K | 2021-07-14 |
| 2021-07-14 | S, sale reported on Form 4 | 2 | $84 | 2021-07-14 |
| 2021-07-26 | S, sale reported on Form 4 | 8,949 | $356.0K | 2021-07-27 |
| 2021-07-26 | S, sale reported on Form 4 | 8,949 | $356.0K | 2021-07-27 |
| 2022-05-19 | S, sale reported on Form 4 | 75,000 | $3.0M | 2022-05-23 |
| 2022-05-27 | S, sale reported on Form 4 | 75,000 | $3.1M | 2022-05-31 |
| 2022-06-08 | S, sale reported on Form 4 | 100,000 | $4.2M | 2022-06-10 |
| 2022-09-28 | S, sale reported on Form 4 | 100,000 | $4.1M | 2022-09-30 |
Counted from the Form 4 filings this reporting owner (SEC CIK 1814872) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms